Dr. Bowles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 303-493-7000
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2009 - 2012- University of ColoradoResidency, Internal Medicine, 2005 - 2008
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2005
Certifications & Licensure
CO State Medical License 2007 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
- LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
- Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- Review of Current and Future Medical Treatments in Head and Neck Squamous Cell Carcinoma.Aaron M Lee, Alice N Weaver, Phillip Acosta, Lauren Harris, Daniel W Bowles
Cancers. 2024-10-15 - 1 citationsA Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation.Rona Yaeger, Meredith A McKean, Rizwan Haq, J Thaddeus Beck, Matthew H Taylor
Cancer Discovery. 2024-09-04 - Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis
Clinical Cancer Research. 2024-09-03
Journal Articles
- Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck CancerHilary Somerset, Antonio Jimeno, David Raben, Sana D Karam, Dara L Aisner, Madeleine Kane, Carrie Marshall, Daniel W Bowles, Clinical Cancer Research
Press Mentions
A Fellow Stays Focused on Her GoalsDecember 3rd, 2024- Hope for Chemo Brain: Cannabis Could Improve Sleep and Cognitive Function in Cancer PatientsApril 28th, 2023
Largest-Ever Study of Thyroid Cancer Genetics Finds New Mutations, Suggests ImmunotherapyApril 26th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
